PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.04%
Negative revenue growth while 3141.T stands at 4.51%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.96%
Negative gross profit growth while 3141.T is at 4.06%. Joel Greenblatt would examine cost competitiveness or demand decline.
-21.69%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-24.23%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-22.15%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-22.17%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-22.17%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 3141.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.54%
10Y revenue/share CAGR above 1.5x 3141.T's 6.71%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
56.54%
5Y revenue/share CAGR above 1.5x 3141.T's 6.71%. David Dodd would look for consistent product or market expansions fueling outperformance.
56.54%
3Y revenue/share CAGR above 1.5x 3141.T's 6.71%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.46%
Net income/share CAGR above 1.5x 3141.T's 63.56% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
152.46%
5Y net income/share CAGR above 1.5x 3141.T's 63.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
152.46%
3Y net income/share CAGR above 1.5x 3141.T's 63.56%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
81.73%
10Y equity/share CAGR above 1.5x 3141.T's 16.42%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
81.73%
5Y equity/share CAGR above 1.5x 3141.T's 16.42%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
81.73%
3Y equity/share CAGR above 1.5x 3141.T's 16.42%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.71%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
4.66%
Asset growth above 1.5x 3141.T's 1.46%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.59%
BV/share growth above 1.5x 3141.T's 2.52%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-11.84%
We’re deleveraging while 3141.T stands at 14.19%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.